Pyxis Oncology Inc. (PYXS)
NASDAQ: PYXS
· Real-Time Price · USD
1.21
0.08 (7.08%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.00%
After-hours: Aug 15, 2025, 07:37 PM EDT
Pyxis Oncology Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 12.76M | 19.47M | 12.06M | 25.07M | 29.44M | 11.14M | 14.71M | 25.9M | 53.06M | 179.29M | 198.54M | 223.35M | 247.09M | 274.74M | 133.48M | 142.47M | -8.08M |
Short-Term Investments | 92.67M | 107.46M | 132.76M | 130.65M | 129.06M | 109.63M | 118.25M | 116.77M | 96.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.16M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 449K | 109K | 3.61M | 2.25M | -8.08M |
Receivables | n/a | n/a | n/a | n/a | 8M | 21K | n/a | n/a | n/a | 598K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.44M | 4.75M | 4.05M | 5.31M | 1.47M | 4.27M | 6.13M | 6.64M | 1.47M | 5.41M | 1.47M | 1.47M | 1.47M | 2.17M | 859K | n/a | n/a |
Total Current Assets | 111.87M | 132.44M | 148.87M | 161.04M | 172.38M | 124.6M | 139.09M | 149.3M | 156.18M | 186.61M | 202.81M | 226.59M | 251.26M | 278.67M | 134.34M | 142.94M | 8.08M |
Property-Plant & Equipment | 21.45M | 22.14M | 22.82M | 23.68M | 24.11M | 24.81M | 25.3M | 25.93M | 26.62M | 24.77M | 21.09M | 15.97M | 995K | 1.24M | 1.54M | 1.85M | n/a |
Goodwill & Intangibles | 2.54M | 2.6M | 23.62M | 23.68M | 23.73M | 24.31M | 22.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 24M | 24.74M | 46.44M | 47.35M | 47.84M | 49.12M | 47.6M | 25.93M | 26.62M | 24.77M | 21.09M | 15.97M | 1.44M | 1.35M | 5.15M | 4.11M | -8.08M |
Total Assets | 135.87M | 157.18M | 195.31M | 208.39M | 220.22M | 173.73M | 186.69M | 175.23M | 182.8M | 211.38M | 223.9M | 242.56M | 252.7M | 280.02M | 139.49M | 147.05M | n/a |
Account Payables | 2.85M | 4.86M | 4.87M | 5.47M | 2.29M | 3.9M | 3.31M | 1.3M | 4.03M | 7.1M | 5.51M | 7.82M | 2.06M | 11.95M | 1.93M | 1.27M | n/a |
Deferred Revenue | n/a | n/a | n/a | -11.43M | n/a | 7.66M | 7.19M | n/a | n/a | n/a | n/a | n/a | n/a | 6.33M | 5.46M | 2.24M | n/a |
Short-Term Debt | n/a | 1.45M | n/a | 1.34M | n/a | 1.23M | 1.2M | 527K | n/a | n/a | n/a | n/a | n/a | n/a | 325K | n/a | n/a |
Other Current Liabilities | n/a | 7.39M | n/a | -1.34M | n/a | 6.52M | -2.41M | -527K | n/a | 1.09M | n/a | n/a | n/a | 3.63M | 9.3M | 4.43M | n/a |
Total Current Liabilities | 14.43M | 17.68M | 20.32M | 16.9M | 14.14M | 25.76M | 28.33M | 9.22M | 11.6M | 31.63M | 19.09M | 14.92M | 19.19M | 18.71M | 16.84M | 8.41M | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 194.09M | 196.22M | n/a |
Total Long-Term Liabilities | 18.33M | 18.75M | 21.31M | 21.7M | 21.92M | 22.26M | 20.41M | 20.73M | 19.04M | 18.92M | 16.05M | 15.68M | 2.06M | 12.12M | 194.09M | 196.22M | n/a |
Total Liabilities | 32.76M | 36.43M | 41.63M | 38.59M | 36.06M | 48.02M | 48.75M | 29.95M | 30.64M | 50.55M | 35.15M | 30.6M | 19.19M | 18.71M | 210.93M | 204.64M | n/a |
Total Debt | 19.84M | 20.2M | 20.54M | 20.87M | 20.78M | 21.33M | 21.62M | 21.26M | 20.25M | 18.92M | 16.05M | 15.68M | n/a | 165K | 325K | 481K | n/a |
Common Stock | 62K | 60K | 59K | 59K | 59K | 45K | 44K | 39K | 37K | 34K | 32K | 32K | 32K | 32K | 2K | 2K | n/a |
Retained Earnings | -384.71M | -363.56M | -327.99M | -306.78M | -289.48M | -286.23M | -270.63M | -247.58M | -231.68M | -212.44M | -176.33M | -148.66M | -123.1M | -91.72M | -74.89M | -60.71M | n/a |
Comprehensive Income | 49K | 170K | 351K | -102K | -60K | 63K | -105K | -85K | 696K | n/a | 0.00 | n/a | 0.00 | -0.00 | -21.94M | n/a | -15.64M |
Shareholders Equity | 103.1M | 120.75M | 153.68M | 169.79M | 184.16M | 125.7M | 137.95M | 145.28M | 152.16M | 160.82M | 188.75M | 211.97M | 233.51M | 261.31M | -71.44M | -57.59M | 6.3M |
Total Investments | 92.67M | 107.46M | 132.76M | 130.65M | 129.06M | 109.63M | 118.25M | 116.77M | 96.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.16M |